Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China: A Randomized Controlled Trial
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
CONTEXT: Although chronic Helicobacter pylori infection is associated with gastric cancer, the effect of H pylori treatment on prevention of gastric cancer development in chronic carriers is unknown. OBJECTIVE: To determine whether treatment of H pylori infection reduces the incidence of gastric cancer. DESIGN, SETTING, AND PARTICIPANTS: Prospective, randomized, placebo-controlled, population-based primary prevention study of 1630 healthy carriers of H pylori infection from Fujian Province, China, recruited in July 1994 and followed up until January 2002. A total of 988 participants did not have precancerous lesions (gastric atrophy, intestinal metaplasia, or gastric dysplasia) on study entry. INTERVENTION: Patients were randomly assigned to receive H pylori eradication treatment: a 2-week course of omeprazole, 20 mg, a combination product of amoxicillin and clavulanate potassium, 750 mg, and metronidazole, 400 mg, all twice daily (n = 817); or placebo (n = 813). MAIN OUTCOME MEASURES: The primary outcome measure was incidence of gastric cancer during follow-up, compared between H pylori eradication and placebo groups. The secondary outcome measure was incidence of gastric cancer in patients with or without precancerous lesions, compared between the 2 groups. RESULTS: Among the 18 new cases of gastric cancers that developed, no overall reduction was observed in participants who received H pylori eradication treatment (n = 7) compared with those who did not (n = 11) (P =.33). In a subgroup of patients with no precancerous lesions on presentation, no patient developed gastric cancer during a follow-up of 7.5 years after H pylori eradication treatment compared with those who received placebo (0 vs 6; P =.02). Smoking (hazard ratio [HR], 6.2; 95% confidence interval [CI], 2.3-16.5; P<.001) and older age (HR, 1.10; 95% CI, 1.05-1.15; P<.001) were independent risk factors for the development of gastric cancer in this cohort. CONCLUSIONS: We found that the incidence of gastric cancer development at the population level was similar between participants receiving H pylori eradication treatment and those receiving placebo during a period of 7.5 years in a high-risk region of China. In the subgroup of H pylori carriers without precancerous lesions, eradication of H pylori significantly decreased the development of gastric cancer. Further studies to investigate the role of H pylori eradication in participants with precancerous lesions are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and Grading of Gastritis: The Updated Sydney System
Dixon, M. F., Genta, R. M., Yardley, J. H., & Correa, P. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199610000-00001 · Cited by 5,185
Helicobacter pylori Infection and the Development of Gastric Cancer
Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., & Schlemper, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa001999 · Cited by 4,465
Helicobacter pylori Infection and the Risk of Gastric Carcinoma
Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., & Sibley, R. K. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251603 · Cited by 3,894
Helicobacter pylori Infection and Gastric Carcinoma among Japanese Americans in Hawaii
Nomura, A., Stemmermann, G. N., Chyou, P.-H., Kato, I., Perez-Perez, G. I., & Blaser, M. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251604 · Cited by 1,762
A human model of gastric carcinogenesis.
Corréa, P. (1988) · PubMed · Cited by 1,433
Forman, D., Newell, D. G., Fullerton, F., Yarnell, J. W., Stacey, A. R., Wald, N., & Sitas, F. (1991) · BMJ · doi:10.1136/bmj.302.6788.1302 · Cited by 1,380
An international association between Helicobacter pylori infection and gastric cancer
The EUROGAST Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)90938-d · Cited by 1,155
Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer
Huang, J.-Q., Sridhar, S., Chen, Y., & Hunt, R. H. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70422-6 · Cited by 957
Correa, P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1881 · Cited by 737
Uemura, N., Mukai, T., Okamoto, S., Yamaguchi, S., Mashiba, H., Taniyama, K., Sasaki, N., Haruma, K., Sumii, K., & Kajiyama, G. (1997) · PubMed · Cited by 546
Association of Helicobacter Pylori Infection With Gastric Carcinoma: A Meta-Analysis
Eslick, G. D., Lim, L. L. Y., Byles, J. E., Xia, H. H.-X., & Talley, N. J. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01360.x · Cited by 402
Gastric Dysplasia and Gastric Cancer: Helicobacter pylori, Serum Vitamin C, and Other Risk Factors
You, W.-C. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.19.1607 · Cited by 270
Role of Helicobacter pylori in the Pathogenesis of Gastritis, Peptic Ulcer and Gastric Cancer
Sipponen, P., & Hyvärinen, H. (1993) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529309098333 · Cited by 269
Molecular biology of gastric cancer*
ELRIFAI, W., & POWELL, S. (2002) · Seminars in Radiation Oncology · doi:10.1053/srao.2002.30815 · Cited by 231
Transmission and Clinical Features of Enterovirus 71 Infections in Household Contacts in Taiwan
Chang, L.-Y. (2004) · JAMA · doi:10.1001/jama.291.2.222 · Cited by 216
Green Tea and the Risk of Gastric Cancer in Japan
Tsubono, Y., Nishino, Y., Komatsu, S., Hsieh, C.-C., Kanemura, S., Tsuji, I., Nakatsuka, H., Fukao, A., Satoh, H., & Hisamichi, S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103013440903 · Cited by 213
Determinants of Helicobacter pylori infection and chronic gastritis.
Fontham, E. T. H., Ruiz, B. A., Pérez, A., et al. (1995) · PubMed · Cited by 165
Fukuda, H., Saito, D., Hayashi, S., Hisai, H., Ono, H., Yoshida, S., Oguro, Y., Noda, T., Sato, T., Katoh, M., et al. (1995) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1995.tb02989.x · Cited by 110
McBride, B. F., Karapanos, A. K., Krudysz, A., Kluger, J., Coleman, C. I., & White, C. M. (2004) · JAMA · doi:10.1001/jama.291.2.216 · Cited by 102
Helicobacter pylori in promotion of gastric carcinogenesis
Rugge, M., Cassaro, M., Leandro, G., et al. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02091536 · Cited by 67
Cited by
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D. Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312288 · Cited by 2,946
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Pathogenesis of Helicobacter pylori Infection
Kusters, J. G., van Vliet, A. H. M., & Kuipers, E. J. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00054-05 · Cited by 2,526
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Atherton, J., Axon, A. T. R., Bazzoli, F., Gensini, G. F., Gisbert, J. P., Graham, D. Y., Rokkas, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302084 · Cited by 2,266
Malfertheiner, P., Megraud, F., O'Morain, C., Bazzoli, F., El-Omar, E., Graham, D., Hunt, R., Rokkas, T., Vakil, N., Kuipers, E. J., et al. (2007) · Gut · doi:10.1136/gut.2006.101634 · Cited by 2,240
Metadata
- Authors
- Wong, B. C.-Y., Lam, S. K., Wong, W. M., Chen, J. S., Zheng, T. T., Feng, R. E., Lai, K. C., Hu, W. H. C., Yuen, S. T., Leung, S. Y., Fong, D. Y. T., Ho, J., Ching, C. K., Chen, J. S., & for the China Gastric Cancer Study Group
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2004-01-14
- Volume
- 291
- Issue
- 2
- Pages
- 187
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2082580119
- Cited by
- 1,435
- References
- 20
- FWCI
- 82.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.